IMARC Group, a leading market research company, has recently released a report titled " Medical Cannabis Market Size, Share, Trends and Forecast by Product, Material, Distribution Channel, Pricing, End-User, and Region, 2025-2033." The study provides a detailed analysis of the industry, including the Medical Cannabis market size, share, trends, and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Medical Cannabis Market Overview
The global medical cannabis market size was valued at USD 37.0 Billion in 2024 and is expected to reach USD 68.6 Billion by 2033, growing at a CAGR of 7.1% during the forecast period of 2025-2033. This growth is driven by increasing use in treating substance use disorders, chronic inflammatory and gastrointestinal conditions, and rising demand for CBD-based products. Legalization expansions and increased awareness of therapeutic benefits also contribute to the market's expansion. Find more details at Medical Cannabis Market
Study Assumption Years
● Base Year: 2024
● Historical Year/Period: 2019-2024
● Forecast Year/Period: 2025-2033
Medical Cannabis Market Key Takeaways
● Current Market Size: USD 37.0 Billion in 2024
● CAGR: 7.1%
● Forecast Period: 2025-2033
● Increasing legalization and medicinal acceptance are key market growth drivers.
● Rising clinical trials and commercialization of cannabis-based pharmaceutical products are expanding therapeutic applications.
● Inflating consumer disposable incomes enhance the affordability and preference for medical cannabis products.
● Pharmaceutical industry leads market end-use through extensive R&D and standardized pharmaceutical cannabis development.
● Oral solutions and capsules dominate the administration route due to convenience and dosage accuracy.
● North America holds the largest market share, supported by progressive legal frameworks and wide acceptance.
Claim Your Free "Medical Cannabis" Insights Sample PDF: https://www.imarcgroup.com/medical-cannabis-market/requestsample
Market Growth Factors
The global medical cannabis market is propelled by rising clinical trials, research and development (R&D) activities, and the commercialization of cannabis-based indications. With expanding legalization and acceptance, interest among pharmaceutical companies and medical professionals has increased. Clinical trials provide essential scientific evidence on efficacy and safety, leading to wider adoption. Significant investments in cannabis-based pharmaceutical products contribute to consistent dosing, quality control, and regulatory compliance, integrating medical cannabis more firmly into mainstream healthcare.
Inflating disposable incomes among consumers favorably impact the market. With more financial capacity, individuals explore alternative healthcare treatments, including medical cannabis, which sometimes lacks insurance coverage. This rise in purchasing power supports demand for higher quality products and premium segments. Consumer preferences shift toward holistic and natural remedies, boosting interest in medical cannabis as a complementary treatment option for diverse health conditions.
The emergence of new cannabis-based pharmaceutical products is bolstering the market. Pharmaceutical companies are innovating cannabis-based medications, undergoing rigorous testing and regulatory approvals to ensure safety and efficacy. This advances healthcare providers' confidence and increases prescription rates. Standardization addresses dosage consistency and quality control concerns. The expanding potential applications target chronic pain, neurological disorders, and mental health conditions, broadening medical cannabis market horizons.
Market Segmentation
Species:
● Indica: Dominant segment due to high CBD content and lower THC levels; favored for pain, anxiety, inflammation management, and sleep disorders.
● Sativa
● Hybrid
Derivatives:
● Cannabidiol (CBD)
● Tetrahydrocannabinol (THC): Largest segment driven by psychoactive properties and therapeutic benefits for pain, cancer symptoms, and multiple sclerosis.
● Others
Application:
● Cancer: Largest segment; used to manage chemotherapy-induced nausea, stimulate appetite, and manage cancer-related pain.
● Arthritis
● Migraine
● Epilepsy
● Others
End-Use:
● Pharmaceutical Industry: Largest segment, focused on research, product development, and commercialization of cannabis-based medications.
● Research and Development Centres
● Others
Route of Administration:
● Oral Solutions and Capsules: Largest segment due to convenience, precise dosing, and suitability for non-inhalation consumers.
● Vaporizers
● Topicals
● Others
Region:
● North America
● United States
● Canada
● Asia-Pacific
● Europe
● Germany
● France
● Italy
● Spain
● Netherlands
● Latin America
● Middle East and Africa
Regional Insights
North America dominates the medical cannabis market, attributed to its progressive regulatory environment, widespread product legalization, and increasing patient acceptance. Notably, the United States and Canada lead the movement, driving significant patient demand and substantial investments in medical cannabis research and commercialization. The region's strong healthcare policies and pharmaceutical industry advancements position North America as a critical contributor to the market's global expansion.
Recent Developments & News
In 2020, Canopy Growth Corporation partnered with Acreage Holdings, Inc. in a strategic agreement enabling potential acquisition upon U.S. federal legalization, positioning Canopy Growth for future growth. In 2021, Jazz Pharmaceuticals acquired GW Pharmaceuticals, expanding its cannabinoid-based therapies portfolio and strengthening presence in neurology and rare diseases. Also in 2021, Aurora Cannabis Inc. executed a strategic transformation involving cost-saving initiatives, restructuring, and divestitures, refocusing on core business areas.
Key Players
● Apothecanna
● Aurora Cannabis Inc.
● Canopy Growth Corporation
● Crop King Seeds
● Curaleaf Laboratories
● Jazz Pharmaceuticals, Inc.
● Little Green Pharma
● Mary'S Nutritionals, LLC
● Medical Marijuana, Inc.
● The Cronos Group
● Tilray Brands, Inc.
Ask an Analyst : https://www.imarcgroup.com/request?type=report&id=1053&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302
English
Join our community to interact with posts!